Pfizer sees $15 billion in 2021 sales from COVID-19 vaccine
By Snakers in News
Updated 3 years ago
Pfizer Inc said on Tuesday it expected to generate $15 billion, or about a quarter of its total revenue this year, from the sale of its COVID-19 vaccine that it has developed with German partner BioNTech.